UniView: 60 Uses the Power of the Masimo
Hospital Automation™ Platform to Improve Clinical Workflows and
Hand-off Communication
Masimo (NASDAQ: MASI) today announced its latest automation and
connectivity solution, UniView: 60™. UniView: 60 uses the Masimo
Hospital Automation™ platform to aggregate and display pertinent
patient information on a digital display just outside each
patient’s room, allowing clinicians to familiarize themselves with
the most relevant details of each patient’s case at the door in 60
seconds or less before they see the patient.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200714005351/en/
Masimo UniView: 60™ (Photo: Business
Wire)
UniView: 60 is intended to improve clinical workflows by helping
increase clinicians' awareness of important patient information and
advisories – for example, a patient’s risk of falling,
environmental warnings, lab results, prescription history,
radiological images, monitoring data, and much more – optimally
displayed, based on hospital preferences, to help clinicians
quickly interpret pertinent information. Unlike paper records and
notes, which may display outdated or incorrect information,
UniView: 60 utilizes its connections to various hospital
information systems to display the most appropriate, up-to-date
information directly outside the patient’s room in order to
increase clinical efficiency and improve hand-off communication
between staff.
The hand-off communication process represents an opportunity for
significant improvements in patient safety. When clinical
information is absent, incomplete, erroneous, or delayed, it can
lead to serious patient harm, including medication errors,
inaccurate patient plans, delays in transfer to critical care,
delays in discharge, and repetitive testing.1 Adopting a clear and
consistent communication strategy, as leading institutions like the
University of California, Irvine (UCI) Medical Center have done,
has been shown to reduce ineffective hand-offs by nearly 60%.2
UniView: 60 is designed to be part of just such a strategy to
improve patient safety: by incorporating patient monitoring data
and other data and advisories in a standardized fashion from each
patient’s full EMR history, UniView: 60 can help to make the
hand-off process more consistent and effective.
UniView: 60 is one of many innovations that Masimo is developing
to take advantage of the powerful connectivity and data handling
architecture of the Masimo Hospital Automation platform, which
connects systems across the continuum of care, from bedside
monitors and connected third-party devices to electronic medical
records (EMRs). Powered by ACE™, advanced translation capabilities,
and a robust automation engine, the Masimo Hospital Automation
platform helps to ensure interoperability and the free, secure
movement of data throughout hospital systems. UniView: 60 takes
advantage of this flow of data by optimizing the presentation of
pertinent information about each patient’s case on an
easy-to-interpret, customizable display.
As part of its vision of the hospital of the future and to
further its longstanding commitment to patient safety, UCI Medical
Center has chosen to deploy UniView: 60 in its new acute care unit.
The new unit features the Masimo Root® Patient Monitoring and
Connectivity Platform with Radius-7® wearable Pulse CO-Oximeters®
at every bedside, Patient SafetyNet™ for supplemental remote
monitoring and clinician notification – and at the entrance to each
room, UniView: 60 digital chart displays.
“When UCI Health planned its new acute care unit at UCI Medical
Center, we wanted a system that allows the entire care team to
quickly see and understand a patient’s most critical information in
a way that enhances patient safety and their relationship with the
patient as an individual,” said UCI Health CEO Chad T. Lefteris.
“Today’s clinical environment generates so much data that
physicians, nurses, therapists, and other staff can lose sight of
the patient. Masimo’s Hospital Automation platform and UniView: 60
meet our objectives by providing the comprehensive solution UCI
Health needed to give our patients the best experience possible,
while reinforcing our commitment to improving patient outcomes and
safety.”
Joe Kiani, Founder and CEO of Masimo, said, “We’re delighted to
announce UniView: 60 and be able to deploy it at one of our
excellent local institutions, the University of California Irvine
Medical Center. We’re proud to have been able to help UCI as they
seek to build the hospital of the future. With UniView: 60, their
clinicians are experiencing the power of the Masimo Hospital
Automation platform, which connects data and automates processes
throughout the hospital, and which is now being harnessed to help
ensure that patients get the right care.”
@MasimoInnovates | #Masimo
About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company
that develops and produces a wide array of industry-leading
monitoring technologies, including innovative measurements,
sensors, patient monitors, and automation and connectivity
solutions. Our mission is to improve patient outcomes and reduce
the cost of care. Masimo SET® Measure-through Motion and Low
Perfusion™ pulse oximetry, introduced in 1995, has been shown in
over 100 independent and objective studies to outperform other
pulse oximetry technologies.3 Masimo SET® has also been shown to
help clinicians reduce severe retinopathy of prematurity in
neonates,4 improve CCHD screening in newborns,5 and, when used for
continuous monitoring with Masimo Patient SafetyNet™ in
post-surgical wards, reduce rapid response team activations, ICU
transfers, and costs.6-8 Masimo SET® is estimated to be used on
more than 200 million patients in leading hospitals and other
healthcare settings around the world,9 and is the primary pulse
oximetry at 9 of the top 10 hospitals according to the 2019-20 U.S.
News and World Report Best Hospitals Honor Roll.10 Masimo continues
to refine SET® and in 2018, announced that SpO2 accuracy on RD SET®
sensors during conditions of motion has been significantly
improved, providing clinicians with even greater confidence that
the SpO2 values they rely on accurately reflect a patient’s
physiological status. In 2005, Masimo introduced rainbow® Pulse
CO-Oximetry technology, allowing noninvasive and continuous
monitoring of blood constituents that previously could only be
measured invasively, including total hemoglobin (SpHb®), oxygen
content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®),
Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen
Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient
Monitoring and Connectivity Platform, built from the ground up to
be as flexible and expandable as possible to facilitate the
addition of other Masimo and third-party monitoring technologies;
key Masimo additions include Next Generation SedLine® Brain
Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography
with NomoLine® sampling lines. Masimo’s family of continuous and
spot-check monitoring Pulse CO-Oximeters® includes devices designed
for use in a variety of clinical and non-clinical scenarios,
including tetherless, wearable technology, such as Radius-7® and
Radius PPG™, portable devices like Rad-67™, fingertip pulse
oximeters like MightySat® Rx, and devices available for use both in
the hospital and at home, such as Rad-97®. Masimo hospital
automation and connectivity solutions are centered around the
Masimo Hospital Automation™ platform, and include Iris Gateway®,
Patient SafetyNet, Replica™, Halo ION™, UniView™, UniView: 60™, and
Masimo SafetyNet™. Additional information about Masimo and its
products may be found at www.masimo.com. Published clinical studies
on Masimo products can be found at
www.masimo.com/evidence/featured-studies/feature/.
ORi and RPVi have not received FDA 510(k) clearance and are not
available for sale in the United States. The use of the trademark
Patient SafetyNet is under license from University HealthSystem
Consortium.
References
- Flemming D and Hübner U. How to Improve Change of Shift
Handovers and Collaborative Grounding and What Role Does the
Electronic Patient Record System Play? Results of a Systematic
Literature Review. Int J Med Inform. 2013 Jul;82(7):580-92.
- Benjamin M, Hargrave S, and Nether K. Using the Target Solution
Tool to Improve Emergency Department Handoffs in a Community
Hospital. Jt Comm J Qual Patient Saf. 2016 Mar;42(3):107-18.
- Published clinical studies on pulse oximetry and the benefits
of Masimo SET® can be found on our website at
http://www.masimo.com. Comparative studies include independent and
objective studies which are comprised of abstracts presented at
scientific meetings and peer-reviewed journal articles.
- Taenzer AH et al. Impact of pulse oximetry surveillance on
rescue events and intensive care unit transfers: a before-and-after
concurrence study. Anesthesiology. 2010:112(2):282-287.
- Taenzer A et al. Postoperative Monitoring – The Dartmouth
Experience. Anesthesia Patient Safety Foundation Newsletter.
Spring-Summer 2012.
- McGrath SP et al. Surveillance Monitoring Management for
General Care Units: Strategy, Design, and Implementation. The Joint
Commission Journal on Quality and Patient Safety. 2016
Jul;42(7):293-302.
- Castillo A et al. Prevention of Retinopathy of Prematurity in
Preterm Infants through Changes in Clinical Practice and SpO2
Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Impact of pulse oximetry screening on
the detection of duct dependent congenital heart disease: a Swedish
prospective screening study in 39,821 newborns. BMJ. 2009;Jan
8;338.
- Estimate: Masimo data on file.
-
http://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview.
About UCI Medical Center
UCI Health comprises the clinical enterprise of the
University of California, Irvine. Patients can access UCI Health at
primary and specialty care offices across Orange County and at its
main campus, UCI Medical Center in Orange, California. The 418-bed
acute care hospital provides tertiary and quaternary care,
ambulatory and specialty medical clinics, and behavioral health and
rehabilitation services. UCI Medical Center features Orange
County’s only National Cancer Institute-designated comprehensive
cancer center, high-risk perinatal/neonatal program and American
College of Surgeons-verified Level I adult and Level II pediatric
trauma center and regional burn center. It is the primary teaching
hospital for the UCI School of Medicine. UCI Health serves a region
of nearly 4 million people in Orange County, western Riverside
County and southeast Los Angeles County. Follow us on Facebook and
Twitter.
Forward-Looking Statements
This press release includes forward-looking statements as
defined in Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934, in connection with the
Private Securities Litigation Reform Act of 1995. These
forward-looking statements include, among others, statements
regarding the potential effectiveness of Masimo UniView: 60™ and
Hospital Automation™. These forward-looking statements are based on
current expectations about future events affecting us and are
subject to risks and uncertainties, all of which are difficult to
predict and many of which are beyond our control and could cause
our actual results to differ materially and adversely from those
expressed in our forward-looking statements as a result of various
risk factors, including, but not limited to: risks related to our
assumptions regarding the repeatability of clinical results; risks
related to our belief that Masimo's unique noninvasive measurement
technologies, including Masimo UniView: 60 and Hospital Automation,
contribute to positive clinical outcomes and patient safety; risks
related to our belief that Masimo noninvasive medical breakthroughs
provide cost-effective solutions and unique advantages; risks
related to COVID-19; as well as other factors discussed in the
"Risk Factors" section of our most recent reports filed with the
Securities and Exchange Commission ("SEC"), which may be obtained
for free at the SEC's website at www.sec.gov. Although we believe
that the expectations reflected in our forward-looking statements
are reasonable, we do not know whether our expectations will prove
correct. All forward-looking statements included in this press
release are expressly qualified in their entirety by the foregoing
cautionary statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of today's date. We do not undertake any obligation to update,
amend or clarify these statements or the "Risk Factors" contained
in our most recent reports filed with the SEC, whether as a result
of new information, future events or otherwise, except as may be
required under the applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200714005351/en/
Media Contacts: Masimo Evan Lamb 949-396-3376 elamb@masimo.com
UCI Medical Center John Murray 714-456-7759 jdmurray@hs.uci.edu
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Apr 2023 to Apr 2024